Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2009 063 506.9 |
96 | EP file number | EAKZ | 14 17 8827.3 |
97 | EP publication number | EPN | 2799088 |
54 | Designation/title | TI | Faktor-VIII-Polymer-Konjugate |
51 | IPC main class | ICM (ICMV) | A61K 47/61 (2017.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 47/60 (2017.01), A61P 7/04 (2006.01), C07K 14/745 (2006.01), A61K 38/37 (2006.01) |
22 | DE application date | DAT | Jul 29, 2009 |
96 | EP application date | EAT | Jul 29, 2009 |
43 | Date of first publication | OT | Nov 5, 2014 |
| Date of publication of grant | PET | Mar 24, 2021 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, Osaka-shi, JP |
72 | Inventor | IN | Turecek, Peter, 3400 Klosterneuburg, AT; SIEKMANN, Juergen, 1210 Vienna, AT |
74 | Representative | VTR | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Address for service | | HOFFMANN-EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 184567 Aug 1, 2008
|
| Due date | FT FG | Jul 31, 2025 Annual fee for the 17th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002799088 Searchable text:
EP000002799088 Original document:
EP000002799088B1 Searchable text:
EP000002799088B1 |
43 | Date of first publication | EVT | Nov 5, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Dec 19, 2014 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 9, 2024 (Show all update days)(Hide all update days)- Aug 9, 2024
- St.36: changed (technical change)
- Jun 28, 2024; May 9, 2024; Jun 27, 2023; Jul 14, 2022; Mar 10, 2022; Feb 17, 2022; Aug 11, 2021; Jul 27, 2021; Jul 23, 2021; Apr 8, 2021; Mar 4, 2021; Nov 21, 2019; Nov 7, 2019; Nov 21, 2017
- Historical data not available for this/these date(s)
- Dec 19, 2014
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 26, 2021 |
| Issue number | HN | 35 |
| Year | PJ | 2021 |
| Publication date | VT | Sep 2, 2021 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, Osaka-shi, JP |
71/73 | Previous applicant/owner | INHF | Baxalta GmbH, Glattpark, (Opfikon), CH, Baxalta Incorporated, Bannockburn, Ill., US |
| Date of update of the procedure | REGT | Aug 11, 2021 |